Klausner Richard 4
4 · Juno Therapeutics, Inc. · Filed Dec 22, 2017
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Sale
Common Stock
2017-12-21$44.72/sh−32,859$1,469,507→ 744,392 total - Sale
Common Stock
2017-12-21$45.16/sh−3,141$141,849→ 741,251 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $44.12 to $45.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $45.12 to $45.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.